First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2026 revenue reaching $119M — +21.7% growth in a single year.
Why Revenue Could Accelerate
1The recent partnership with a major healthcare provider to integrate Butterfly iQ into their diagnostic workflow could increase device adoption by 25% over the next year.
2Expansion into the European market is expected to drive a 30% increase in international sales by the end of FY26.
3New software updates enhancing imaging capabilities have received positive feedback from early adopters, suggesting potential for increased subscription revenue.
4Regulatory approval for a new pediatric ultrasound application is anticipated, which could open up a new customer segment and increase market share.
5Telemedicine and remote diagnostics growth
6Shift towards portable medical devices in healthcare
7Regulatory approvals for new product features or devices
8Expansion into international markets, particularly in Europe and Asia
The bull case is simple: analysts see revenue climbing from $119M to $142M as the recent partnership with a major healthcare provider to integrate butterfly iq into their diagnostic workflow could.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.